Fund moves

Legence (LGN): Conestoga Capital Advisors, LLC opened a new position $23.5M

Conestoga Capital Advisors, LLC opened a new position in Legence, per its Q1 2026 13F.

416K
Shares reported
0.47%
Disclosed portfolio weight
$23.5M
Reported value
Holdings as of
Mar 31, 2026
Filed
Apr 24, 2026

What stands out in this filing

  • A new position in Q1 2026: 415,860 shares, none in the manager's Q4 2025 filing.
  • Reported at $23.5M, 0.47% of the portfolio value in this 13F filing.
  • 3 other tracked managers reported the same kind of change for Q1 2026.

Calculated by OQRO from this filing and the public records it holds. Facts about the record, not a reason for the trade and not a signal.

The story around this disclosure

Every dated public record OQRO holds about the company from 60 days before to 120 days after, oldest first. It shows what was going on; none of it is a stated reason for the trade.

  1. Mar 3, 2026CongressDisclosed purchase of LGN — reported range $1,001 - $15,000
  2. Mar 27, 2026Company filing · Form 8-K · ResultsReported its results

What came next

  1. May 14, 2026Company filing · Form 8-K · ResultsReported its results
  2. Jun 11, 2026Company filing · Form 8-K · Executive change, Shareholder voteChanged a top executive or board member, and held a shareholder vote“Legence Corp. (the “Company”) held its 2026 Annual Meeting of Stockholders (the “Annual Meeting”) on June 11, 2026. At the Annual Meeting, the Company’s stockholders approved the Legence Corp. 2026 Employee Stock Purchase Plan (the “ESPP”), which had been previously approved by the Company’s Board of Directors, subject to stockholder approval.”
  3. Aug 13, 2026Company filing · Form 8-K · ResultsReported its results
  4. Aug 18, 2026Company filing · Form 8-K · Executive changeChanged a top executive or board member“On August 18, 2026, the Board of Directors (the “Board”) of Legence Corp., a Delaware corporation (the “Company”), increased the size of the Board from six to seven directors and appointed Mr. Robert Crisci to the Board as a Class II director to fill the vacancy created by such increase, effective as of August 18, 2026.”
View the official recordSEC Form 13F-HR

How to read SEC Form 13F-HR

Form 13F is the quarterly report in which investment managers that oversee $100 million or more list the US-listed stocks and some other securities they held on the last day of the quarter.

Full guide: What is an SEC Form 13F?

What else is on file for Legence

For Legence, OQRO holds 1 fund holdings report (13F) dated in the last 90 days.

These are records OQRO holds, counted by their date, not a measure of how much trading took place. Routine paperwork such as option exercises and tax withholding is left out. Everything for the company is on its LGN page.

How this filing works

Explore the data

Common questions

What does this filing report about Legence (LGN) stock?

Conestoga Capital Advisors, LLC opened a new position in Legence, per its Q1 2026 13F. 416K shares reported, 0.47% of disclosed portfolio.

When did it happen, and when was it made public?

Holdings as of: Mar 31, 2026. Filed: Apr 24, 2026.

What stands out in this filing?

A new position in Q1 2026: 415,860 shares, none in the manager's Q4 2025 filing. Reported at $23.5M, 0.47% of the portfolio value in this 13F filing. 3 other tracked managers reported the same kind of change for Q1 2026.

Is this a trade made on a known date?

No. A holdings report is a picture of the portfolio on the last day of the quarter. It shows what was held on that day, not the day or the price at which anything was bought or sold.

Where does this information come from?

From the SEC Form 13F-HR, a public record. The link to the official record is on this page, and OQRO copies its figures without changing them.

What else has been disclosed about Legence recently?

For Legence, OQRO holds 1 fund holdings report (13F) dated in the last 90 days. They are listed on the LGN page.

Does this mean LGN stock is a buy or a sell?

No. This page describes one public filing. A filing does not say why someone traded and is not a forecast, so OQRO gives no recommendation.

Is OQRO free?

Yes. Every page of OQRO is free with an account, which takes a minute with Google and needs no card. Only the AI assistant is paid.

Other disclosures at Legence

Everything OQRO holds on this company is on its LGN page.

This is one filing. OQRO holds the rest

Insider trades filed with the SEC, stock trades disclosed by members of Congress, fund holdings from 13F filings and federal contract awards, each one in plain words next to its official filing. On this page it opens why the trade stands out, what the company did around that time, the price since, and every field of the form.

OQRO is free for everyone. No card, no trial

OQRO describes public disclosures and context calculated from them. It does not give personalized advice and does not recommend any transaction. How OQRO treats data